EOF: Export of 82 drugs frozen for 3 months

The National Organization for Medicines (EOF) in Greece has announced a temporary prohibition on the parallel export and intra-community movement of 82 pharmaceutical products. This decision follows an assessment of the adequacy of these specific medications within the Greek market. The measure is designed to safeguard the supply chain and ensure that essential medicines remain accessible to patients in Greece.

The ban will remain in effect for three months, concluding on August 27. During this period, the stockpiling of the affected pharmaceutical preparations is also prohibited. The EOF emphasizes that the primary focus is on ensuring the availability of these drugs for patients within Greece, prioritizing their distribution according to demand and legal prescriptions. This applies to all pharmaceutical products circulating in Greece, including those approved for emergency import or exceptional circulation with foreign-language labeling.

EOF stressed that all links in the distribution chain, license holders, pharmaceutical wholesalers, and pharmacies, must prioritize supplying medicines to patients in Greece. The organization will actively monitor adherence to these adequacy obligations. Failure to adequately cover patient needs will result in sanctions. EOF also stated that it continuously monitors the market's drug supply and may modify, partially lift, or extend the ban depending on evolving needs.

Furthermore, the EOF will investigate reported instances of limited availability or supply interruptions communicated by license holders, patients, or healthcare professionals. The organization is committed to taking necessary measures to prevent drug shortages and avoid any therapeutic gaps, ensuring that patients receive the treatments they require without interruption.